tiprankstipranks
Advertisement
Advertisement
Alps Group Publishes Peer-Reviewed Data Backing Safety of Novel NK Cell Therapy Platform
PremiumCompany AnnouncementsAlps Group Publishes Peer-Reviewed Data Backing Safety of Novel NK Cell Therapy Platform
5M ago
Alps Group Publishes Pro Forma Results After $1.6 Billion Business Combination With Globalink
Premium
Company Announcements
Alps Group Publishes Pro Forma Results After $1.6 Billion Business Combination With Globalink
6M ago
Alps Group Explores Exosome Pipeline Expansion After Promising Asthma and COPD Case Series
Premium
Company Announcements
Alps Group Explores Exosome Pipeline Expansion After Promising Asthma and COPD Case Series
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100